Generic drugs in Taiwan are registered through an abbreviated review process, focusing on bioequivalence studies to demonstrate that they are as effective and safe as the original product. Applicants must submit quality control data and ensure Good Manufacturing Practice (GMP) compliance. The TFDA may expedite approval if the documentation is complete and valid.